In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Harald Darius
Harald Darius Harald Darius

Vivantes Neukoelln Medical Center, Berlin (Germany)

Specialities : Acute Coronary Syndromes , Chronic Heart Failure

15 presentations from this speaker

10 years since RE-LY: applying innovations in anticoagulation

Event : ESC Congress 2019

  • Session : 10 years since RE-LY: applying innovations in anticoagulation
  • Speaker : E Hylek (Boston,US), H Darius (Berlin,DE)
  • Sponsored by Boehringer Ingelheim

Current practice of dual antiplatelet therapy in patients with diabetes

Event : ESC Congress 2019

  • Session : Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)
  • Speaker : H Darius (Berlin,DE)
  • Supported by an unrestricted educational grant from AstraZeneca

Discussion

Event : ESC Congress 2019

  • Session : Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)
  • Speaker : M Bonaca (Boston,US), P Steg (Paris,FR), H Darius (Berlin,DE), KK Ray (London,GB)
  • Supported by an unrestricted educational grant from AstraZeneca

Panel discussion and Q&A - Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice.

Event : ESC Congress 2018

  • Session : Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice
  • Speaker : E Hylek (Boston,US), H Darius (Berlin,DE)
  • Sponsored by Boehringer Ingelheim

Reversal matters: comprehensive care with dabigatran and idarucizumab.

Event : ESC Congress 2018

  • Session : Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice
  • Speaker : H Darius (Berlin,DE)
  • Sponsored by Boehringer Ingelheim

Immediate dabigatran reversal: changing anticoagulation practice?

Event : ESC Congress 2017

  • Session : Immediate dabigatran reversal: changing anticoagulation practice?
  • Speaker : H Darius (Berlin,DE), R Whitlock (Hamilton,CA), P Verhamme (Leuven,BE)
  • Sponsored by Boehringer Ingelheim

From clinical evidence to real world experience: non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation and common comorbidities.

Event : Heart Failure 2016

  • Session : Oral anticoagulation in patients with heart failure: today and tomorrow
  • Speaker : H Darius (Berlin,DE)
  • Sponsored by Bayer

Optimising patient care with NOACs – Panel discussion.

Event : ESC Congress 2016

  • Session : Oral anticoagulation, thrombosis and bleeding – Improving patient care with NOACs
  • Speaker : H Darius (Berlin,DE), F Andreotti (Rome,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Oral anticoagulation – Managing challenging patients with NVAF.

Event : ESC Congress 2016

  • Session : Oral anticoagulation, thrombosis and bleeding – Improving patient care with NOACs
  • Speaker : H Darius (Berlin,DE)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Vorapaxar: for which patients?

Event : Acute Cardiovascular Care 2016

  • Session : Secondary prevention after acute coronary syndromes
  • Speaker : H Darius (Berlin,DE)
  • Joint session with the European Association of Preventive Cardiology (EAPC)

Clinical challenges in oral anticoagulation: your questions discussed.

Event : ESC Congress 2015

  • Session : Clinical challenges in oral anticoagulation: your questions discussed
  • Speaker : GYH Lip (Liverpool,GB), H Darius (Berlin,DE), A Cohen (London,GB)
  • Sponsored by BMS-Pfizer Alliance

Prevention of ischemic and hemorrhagic stroke: a case for NOAC selection?

Event : Acute Cardiovascular Care 2015

  • Session : Neurologic emergencies and acute cardiac care
  • Speaker : H Darius (Berlin,DE)

What is the current role of new oral anticoagulants (or VKAs) in the early acute management of atrial fibrillation?

Event : Acute Cardiovascular Care 2015

  • Session : Unmet needs in medical therapies for atrial fibrillation
  • Speaker : H Darius (Berlin,DE)

What do the latest cardiovascular outcomes studies in mean to a cardiologist?

Event : ESC Congress 2013

  • Session : Join the conversation: clinical implications of the latest cardiovascular outcomes studies in type 2 diabetes
  • Speaker : H Darius (Berlin,DE)
  • Sponsored by Bristol-Myers Squibb and AstraZeneca

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are